Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for ongoing cancer-related pain despite standard therapy
ACTRN12615000087550Phase 3Terminated
- Sponsor
- Mater Misericordiae University Hospital
- Start
- Oct 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in cancer pain comparing Dexamethasone plus usual care with Placebo saline plus usual care (2 arms). Primary endpoint: Feasibility completion rate. Started Oct 2015; status: terminated.
02
Drugs
dexamethasone
03
Conditions
cancer pain
Beyond the preview
Go deeper on ACTRN12615000087550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000087550.